Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-03 | 2025-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | M - OptEx | — | +128.9K | 306.4K | +73% | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | F - Tax | $0.67 | -45.6K | 260.8K | -15% | -$30.6K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | M - OptEx | — | -128.9K | 138.8K | -48% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | M | A | 26,097 | — | 203,594 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2025-02-28 | M | A | 33,456 | — | 237,050 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2025-02-28 | M | A | 69,387 | — | 306,437 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2025-02-28 | F | D | 45,622 | $0.67 | 260,815 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 26,097 | — | 0 | D | — · — to — | 26,097 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 33,456 | — | 33,457 | D | — · — to — | 33,456 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 69,387 | — | 138,773 | D | — · — to — | 69,387 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |